XRCC5 and Stroke: XRCC5 is associated with the development of the thalidomide-related thrombosis as the response to the red blood cell apoptosis, which may associate to the formation of venous thrombosis and the development of CAD, PVD, stroke, and other cardiac diseases [35–37].